Champions Oncology, Inc. (CSBR) Social Stream
CHAMPIONS ONCOLOGY INC (CSBR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CSBR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-15 | 1 | $16 | $14 | $15 | $6.15 | 143.9% |
| 2022-03-22 | 1 | $13 | $13 | $13 | $6.15 | 111.38% |
| 2022-04-14 | 2 | $14 | $13 | $13.5 | $6.15 | 119.51% |
| 2022-08-01 | 2 | $16 | $14 | $15 | $6.15 | 143.9% |
| 2022-09-21 | 2 | $15 | $14 | $14.5 | $6.15 | 135.77% |
| 2023-01-19 | 2 | $14 | $9 | $11.5 | $6.15 | 86.99% |
| 2023-03-20 | 2 | $9 | $9 | $9 | $6.15 | 46.34% |
| 2023-09-22 | 2 | $7.5 | $7.5 | $7.5 | $6.15 | 21.95% |
| NA | 1 | $NA | $NA | $NA | $6.15 | NA% |
The Trend in the Analyst Price Target
Over the past 26 months, CSBR's average price target has gone down $8.17.
Over the past 35 weeks, CSBR's average upside potential has been 127.72%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-19 | 2 | 14.0 | 9.0 | 11.5 | 4.41 | 160.77% |
| 2023-03-20 | 2 | 14.0 | 9.0 | 11.5 | 4.01 | 186.78% |
| 2023-03-20 | 2 | 9.0 | 9.0 | 9.0 | 4.01 | 124.44% |
| 2023-09-22 | 2 | 7.5 | 7.5 | 7.5 | 5.40 | 38.89% |
CSBR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
CSBR's average broker recommendation rating worsened by 1 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CSBR as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, CHAMPIONS ONCOLOGY INC's number of analysts covering the stock is higher than 16.98% of them.
- In terms of how CHAMPIONS ONCOLOGY INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 49.94% of that group.
- In terms of how CHAMPIONS ONCOLOGY INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 203.39% of that group.
- CSBR has a higher upside potential (average analyst target price relative to current price) than 334.41% of stocks in the micro market cap category.
Stocks similar to CHAMPIONS ONCOLOGY INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CDTX, NAII, and MREO.
View All Top Stocks by Price Target
What is the outlook for CSBR? Use POWR Ratings for clearer insight into price direction.